157 related articles for article (PubMed ID: 21092351)
1. Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive impairment and dementia.
Foley JM; Wright MJ; Gooding AL; Ettenhofer M; Kim M; Choi M; Castellon SA; Sadek J; Heaton RK; van Gorp WG; Marcotte TD; Hinkin CH
Int Psychogeriatr; 2011 Jun; 23(5):835-43. PubMed ID: 21092351
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
3. Utility of the Montreal Cognitive Assessment (MoCA) and its subset in HIV-associated neurocognitive disorder (HAND) screening.
Kim WJ; Ku NS; Lee YJ; Ahn JY; Kim SB; Ahn HW; Hong KW; Song JY; Cheong HJ; Kim WJ; Kim JM; Namkoong K; Choi JY; Kim E
J Psychosom Res; 2016 Jan; 80():53-7. PubMed ID: 26721548
[TBL] [Abstract][Full Text] [Related]
4. Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV.
Chiao S; Rosen HJ; Nicolas K; Wendelken LA; Alcantar O; Rankin KP; Miller B; Valcour V
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):949-56. PubMed ID: 23432363
[TBL] [Abstract][Full Text] [Related]
5. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
[TBL] [Abstract][Full Text] [Related]
6. Updated research nosology for HIV-associated neurocognitive disorders.
Antinori A; Arendt G; Becker JT; Brew BJ; Byrd DA; Cherner M; Clifford DB; Cinque P; Epstein LG; Goodkin K; Gisslen M; Grant I; Heaton RK; Joseph J; Marder K; Marra CM; McArthur JC; Nunn M; Price RW; Pulliam L; Robertson KR; Sacktor N; Valcour V; Wojna VE
Neurology; 2007 Oct; 69(18):1789-99. PubMed ID: 17914061
[TBL] [Abstract][Full Text] [Related]
7. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.
Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A
AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560
[TBL] [Abstract][Full Text] [Related]
8. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
[TBL] [Abstract][Full Text] [Related]
9. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
[TBL] [Abstract][Full Text] [Related]
10. Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders.
Shirazi TN; Summers AC; Smith BR; Steinbach SR; Kapetanovic S; Nath A; Snow J
AIDS Behav; 2017 Jul; 21(7):2124-2134. PubMed ID: 28108876
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.
Tierney SM; Sheppard DP; Kordovski VM; Faytell MP; Avci G; Woods SP
J Neurovirol; 2017 Jun; 23(3):404-421. PubMed ID: 28108972
[TBL] [Abstract][Full Text] [Related]
12. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.
Heaton RK; Clifford DB; Franklin DR; Woods SP; Ake C; Vaida F; Ellis RJ; Letendre SL; Marcotte TD; Atkinson JH; Rivera-Mindt M; Vigil OR; Taylor MJ; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Abramson I; Gamst A; Fennema-Notestine C; Jernigan TL; Wong J; Grant I;
Neurology; 2010 Dec; 75(23):2087-96. PubMed ID: 21135382
[TBL] [Abstract][Full Text] [Related]
13. Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning.
Cattie JE; Doyle K; Weber E; Grant I; Woods SP;
J Clin Exp Neuropsychol; 2012; 34(9):906-18. PubMed ID: 22731608
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive subgroups in major depressive disorder.
Martin DM; Wollny-Huttarsch D; Nikolin S; McClintock SM; Alonzo A; Lisanby SH; Loo CK
Neuropsychology; 2020 Sep; 34(6):726-734. PubMed ID: 32324004
[TBL] [Abstract][Full Text] [Related]
15. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings.
Blackstone K; Moore DJ; Franklin DR; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Ellis RJ; Atkinson JH; Grant I; Heaton RK
Clin Neuropsychol; 2012; 26(6):894-908. PubMed ID: 22708483
[TBL] [Abstract][Full Text] [Related]
16. Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementia.
Suarez SV; Stankoff B; Conquy L; Rosenblum O; Seilhean D; Arvanitakis Z; Lazarini F; Bricaire F; Lubetzki C; Hauw JJ; Dubois B
Eur J Neurol; 2000 Mar; 7(2):151-8. PubMed ID: 10809935
[TBL] [Abstract][Full Text] [Related]
17. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
[TBL] [Abstract][Full Text] [Related]
18. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.
Kinai E; Komatsu K; Sakamoto M; Taniguchi T; Nakao A; Igari H; Takada K; Watanabe A; Takahashi-Nakazato A; Takano M; Kikuchi Y; Oka S;
J Neurovirol; 2017 Dec; 23(6):864-874. PubMed ID: 28971376
[TBL] [Abstract][Full Text] [Related]
19. [Cognition disorders in HIV infection. Validation of a brief neuropsychological evaluation battery].
Desi M; Seibel N; Korezlioglu J; Silvestre D; Linard F
Encephale; 1995; 21(4):289-94. PubMed ID: 7588168
[TBL] [Abstract][Full Text] [Related]
20. The HIV Dementia Scale: predictive power in mild dementia and HAART.
Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
